InjuryBoard Grand Junction Archives

  • Zelnorm Back on the Market

    Jenny Albano | July 27, 2007 1:01 PM | 0 Comments
    Category: FDA & Prescription Drugs

    The drug Zelnorm, manufactured by Novatis, was taken of the market in March because of a high risk of heart attacks, stroke, and chest pain. But now the FDA is allowing the irritable bowel syndrome drug to become available again, but only for a restricted access program. Zelnorm will remain off the market for the general public.The program is for women in the US under 55 years of age who...

  • Public Citizen Alerts Public of Class Action Against Paxil on You Tube

    Jenny Albano | July 18, 2007 7:26 PM | 0 Comments
    Category: FDA & Prescription Drugs

    Public Citizen, a consumer advocacy group, decided advertise a class action suit a little differently. The group of lawyers used You Tube, a popular video website, to announce a $48 million class action settlement for people who had purchased Paxil for their kids.There are two videos up on the website. The first video that shows a teenager wandering around looking confused, and then a news...

Subscribe to InjuryBoard Grand Junction

InjuryBoard Grand Junction RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Grand Junction, Colorado brought to you by Bachus & Schanker, LLC

Legal Assistance Center

More Info
Bachus & Schanker, LLC (866) 735-1102 Ext 425 www.coloradolaw.net
google
Personal Injury Lawyers Serving: Denver, Fort Collins, Colorado Spring, Grand Junction, Cheyenne and all surrounding areas. Offices in Denver, Fort Collins and Colorado Springs
1400 16th StreetSuite 450, Denver, Colorado 80202 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.